Minzhen Xu
Net worth: 408 000 $ as of 2024-05-30
Profile
Minzhen Xu worked as a Vice President at NuGenerex Immuno-Oncology, Inc.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2023-09-26 | 400,000 ( 5.95% ) | 408 000 $ | 2024-05-30 |
Former positions of Minzhen Xu
| Companies | Position | End |
|---|---|---|
| NUGENEREX IMMUNO-ONCOLOGY, INC. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
NuGenerex Immuno-Oncology, Inc.
 NuGenerex Immuno-Oncology, Inc. BiotechnologyHealth Technology NuGenerex Immuno-Oncology, Inc. is an oncology company focuses on the modulation of the immune system to treat cancer. It develops immunotherapeutic products and vaccines based on proprietary, patented platform technology, Ii-Key. The Ii-Key is a peptide derived from the major histocompatibility complex (MHC) class II associated invariant chain that regulates the formation, trafficking, and antigen-presenting functions of MHC class II complexes, essential for the activation of T cells in the immune response. The company was founded on October 8, 1993 and is headquartered in Miramar, FL. | Health Technology |
- Stock Market
- Insiders
- Minzhen Xu
